14-day Premium Trial Subscription Sign Up For FreeGet Free

Aclaris Therapeutics Stock Forecast NASDAQ:ACRS

Price Target and Analyst Ratings

Most Recent Rating

On September 02, 2021 "HC Wainwright" gave "$50.00" rating for ACRS. The price target was set to $18.13+5.3%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-02 $50.00 Reiterated by HC Wainwright $17.60 $18.13+5.3%
2021-08-09 $50.00 Reiterated by HC Wainwright $14.60 $14.90+0.9%
2021-08-08 $26.00 Reiterated by SVB Leerink $14.90 $14.90+0.0%
2021-07-23 $32.00 Initiated by Jefferies Financial Group $15.70 $15.70+0.6%
2021-06-16 Positive - Buy Reiterated by HC Wainwright $17.99
2021-06-15 Overweight Initiated by Piper Sandler $17.81
2021-04-27 Buy Initiated by HC Wainwright $24.62
2021-04-21 Buy Initiated by HC Wainwright $27.20
2021-03-10 Outperform Target Raised by SVB Leerink $22.82 $21.00 → $26.00
2021-02-02 Positive - Overweight Target Raised by Cantor Fitzgerald $20.73 $15.00 → $30.00

ACRS Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $17.73 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -6.92% during the next 3 months and, with a 90% probability hold a price between $12.06 and $16.50 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $12.94 $15.32 $17.71
2021-09-21 $12.92 $15.30 $17.69
2021-09-22 $12.90 $15.28 $17.66
2021-09-23 $12.88 $15.26 $17.64
2021-09-24 $12.86 $15.24 $17.62
2021-09-27 $12.84 $15.22 $17.60
2021-09-28 $12.81 $15.20 $17.58
2021-09-29 $12.79 $15.18 $17.56
2021-09-30 $12.77 $15.16 $17.54
2021-10-01 $12.75 $15.13 $17.52
2021-10-04 $12.73 $15.11 $17.50
2021-10-05 $12.71 $15.09 $17.48
2021-10-06 $12.69 $15.07 $17.46
2021-10-07 $12.67 $15.05 $17.43
2021-10-08 $12.65 $15.03 $17.41
2021-10-11 $12.63 $15.01 $17.39
2021-10-12 $12.61 $14.99 $17.37
2021-10-13 $12.58 $14.97 $17.35
2021-10-14 $12.56 $14.95 $17.33
2021-10-15 $12.54 $14.93 $17.31
2021-10-18 $12.52 $14.90 $17.29
2021-10-19 $12.50 $14.88 $17.27
2021-10-20 $12.48 $14.86 $17.25
2021-10-21 $12.46 $14.84 $17.22
2021-10-22 $12.44 $14.82 $17.20
2021-10-25 $12.42 $14.80 $17.18
2021-10-26 $12.40 $14.78 $17.16
2021-10-27 $12.38 $14.76 $17.14
2021-10-28 $12.35 $14.74 $17.12
2021-10-29 $12.33 $14.72 $17.10

About Aclaris Therapeutics

Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription t... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT